Public Employees Retirement System of Ohio Boosts Stock Position in Inspire Medical Systems, Inc. (NYSE:INSP)

Public Employees Retirement System of Ohio raised its holdings in Inspire Medical Systems, Inc. (NYSE:INSP - Free Report) by 9.4% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 36,361 shares of the company's stock after acquiring an additional 3,125 shares during the period. Public Employees Retirement System of Ohio owned approximately 0.12% of Inspire Medical Systems worth $7,674,000 at the end of the most recent reporting period.

Several other hedge funds have also bought and sold shares of the stock. AQR Capital Management LLC raised its position in Inspire Medical Systems by 152.7% during the second quarter. AQR Capital Management LLC now owns 231,845 shares of the company's stock valued at $31,028,000 after purchasing an additional 140,090 shares in the last quarter. B. Metzler seel. Sohn & Co. Holding AG purchased a new position in shares of Inspire Medical Systems in the third quarter worth $1,929,000. SG Americas Securities LLC increased its holdings in Inspire Medical Systems by 114.2% during the 2nd quarter. SG Americas Securities LLC now owns 6,228 shares of the company's stock valued at $833,000 after purchasing an additional 3,321 shares during the period. Thrivent Financial for Lutherans raised its holdings in shares of Inspire Medical Systems by 39.7% during the third quarter. Thrivent Financial for Lutherans now owns 110,580 shares of the company's stock valued at $23,337,000 after acquiring an additional 31,444 shares in the last quarter. Finally, Headlands Technologies LLC purchased a new stake in shares of Inspire Medical Systems in the 2nd quarter worth about $1,391,000. 94.91% of the stock is currently owned by institutional investors.

Inspire Medical Systems Price Performance

Shares of NYSE INSP traded down $2.04 during midday trading on Friday, reaching $187.96. 431,232 shares of the stock traded hands, compared to its average volume of 586,183. Inspire Medical Systems, Inc. has a one year low of $123.00 and a one year high of $257.40. The stock has a market capitalization of $5.63 billion, a PE ratio of 174.15 and a beta of 1.31. The company's 50 day moving average is $194.84 and its 200 day moving average is $178.35.

Inspire Medical Systems (NYSE:INSP - Get Free Report) last announced its earnings results on Monday, November 4th. The company reported $0.60 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.06 by $0.54. The firm had revenue of $203.20 million for the quarter, compared to analysts' expectations of $197.59 million. Inspire Medical Systems had a net margin of 4.37% and a return on equity of 5.30%. The business's revenue was up 32.6% compared to the same quarter last year. During the same period in the prior year, the company earned ($0.29) EPS. As a group, equities analysts forecast that Inspire Medical Systems, Inc. will post 1.33 EPS for the current year.

Analyst Ratings Changes

INSP has been the topic of a number of recent research reports. Stifel Nicolaus restated a "hold" rating and issued a $200.00 price objective (up previously from $170.00) on shares of Inspire Medical Systems in a report on Tuesday, November 5th. Piper Sandler reiterated an "overweight" rating and set a $260.00 price objective (up previously from $255.00) on shares of Inspire Medical Systems in a research note on Tuesday, November 5th. Royal Bank of Canada reissued an "outperform" rating and issued a $260.00 target price on shares of Inspire Medical Systems in a research note on Tuesday, November 5th. Bank of America raised Inspire Medical Systems from a "neutral" rating to a "buy" rating and lifted their price target for the stock from $220.00 to $255.00 in a research report on Wednesday, November 20th. Finally, Leerink Partners upped their price target on shares of Inspire Medical Systems from $167.00 to $197.00 and gave the stock a "market perform" rating in a research note on Tuesday, September 10th. Three analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $233.58.

About Inspire Medical Systems

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.